Adneuris Therapeutics, a wholly-owned subsidiary of Tris Pharma advancing a new kind of pain medicine, announced that it has ...

Cambridge, USA-based mRNA vaccines company Moderna announced that the US Food and Drug Administration (FDA) has approved ...

German science and technology group Merck KGaA (MRK: DE) has upgraded its full-year outlook after a second quarter in which its laboratory and semiconductor materials businesses more than covered a ...

There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a potential deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted ...

For decades, the pharmaceutical industry has largely focused on discovering new molecules. Laxxon Medical believes the next ...

US biotech Amgen reported a 10% increase in second-quarter 2026 revenue, as growth from Repatha (evolocumab), Evenity ...

US drugmaker Gilead Sciences raised the lower end of its 2026 sales guidance after second-quarter revenue beat expectations, driven by continued growth in HIV and oncology.

Swiss affordable medicines company Sandoz today presented its financial results for the first half of 2026 and net-sales ...

USA-based biotech major Amgen (Nasdaq: AMGN) has disclosed what it called a material cybersecurity incident, in which hackers ...

The US Food and Drug Administration (FDA) has approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) in combination with ...

UK and USA-based biotech Tiziana Life Sciences has announced quantitative PET imaging results from the third patient with ...

Medicines regulators recorded a relatively quiet week in the seven days to 3 August 2026, with the USA accounting for the ...